Compounds of Formula 1 ##STR00001## and pharmaceutically acceptable salts thereof, wherein m, Ar, R.sup.1, R.sup.2, and R.sup.3 are as defined herein. The invention also provides methods for preparing, coompositions comprising, and methods for using compounds of Formula 1 for treatment of central nervous system disorders.